findmyKOL

Samer Alsidawi, MD

Basic profile

TriHealth

ORCIDNPI
RegionCincinnati, OH · MidwestSpecialtyHematology / OncologyFocusOncology
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Samer Alsidawi is an Oncology physician affiliated with TriHealth. OpenAlex indexes 28 publications with 348 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
28publications

Distinct works indexed by OpenAlex, matched via ORCID.

348citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
24companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5520 Cheviot Rd
Cincinnati, OH 452477069

Telephone

513-451-4033

Registry record last updated 17 Oct 2018.

View the NPPES registry record

Industry payments

24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    27.1%
    Kinase inhibitor9.6%
    Calquence26%Imatinib Mesylate25%Imbruvica23%Brukinsa14%Tasigna12%
    Part D<11 patients
    Thalidomide Analog9.5%
    Lenalidomide45%Pomalyst30%Revlimid25%
    Part D<11 patients

    + 5 more classes in this area

  • Nervous system

    18.5%
    Opioid Agonist6.6%
    Oxycodone Hcl56%Oxycodone-Acetaminophen28%Morphine Sulfate Er16%
    Part D<11 patients
    Phenothiazine3.1%
    Prochlorperazine Maleate100%
    Part D25 patients

    + 4 more classes in this area

  • Anti-infectives

    15.2%
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor10.2%
    Valacyclovir100%
    Part D26 patients
    Fluoroquinolone Antibacterial2.3%
    Levofloxacin100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”